Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance
Issued Date
2024-01-01
Resource Type
eISSN
2214109X
Scopus ID
2-s2.0-85183558513
Pubmed ID
38278160
Journal Title
The Lancet Global Health
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Lancet Global Health (2024)
Suggested Citation
Mendelson M., Laxminarayan R., Limmathurotsakul D., Kariuki S., Gyansa-Lutterodt M., Charani E., Singh S., Walia K., Gales A.C., Mpundu M. Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance. The Lancet Global Health (2024). doi:10.1016/S2214-109X(23)00554-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/95742
Title
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance
Author's Affiliation
Mahidol Oxford Tropical Medicine Research Unit
Ministry of Health Ghana
Kenya Medical Research Institute
Indian Council of Medical Research
Universidade Federal de São Paulo
Amrita Institute of Medical Sciences India
Groote Schuur Hospital
One Health Trust
ReAct Africa
Regional Office for Eastern Africa
Ministry of Health Ghana
Kenya Medical Research Institute
Indian Council of Medical Research
Universidade Federal de São Paulo
Amrita Institute of Medical Sciences India
Groote Schuur Hospital
One Health Trust
ReAct Africa
Regional Office for Eastern Africa
Corresponding Author(s)
Other Contributor(s)
Abstract
To limit the catastrophic effects of the increasing bacterial resistance to antimicrobials on health, food, environmental, and geopolitical security, and ensure that no country or region is left behind, a coordinated global approach is required. In this Viewpoint, we argue that the diverging resource availabilities, needs, and priorities of the Global North and the Global South in terms of the actions required to mitigate the antimicrobial resistance pandemic are a direct threat to success. We argue that evidence suggests a need to prioritise and support infection prevention interventions (ie, clean water and safe sanitation, increased vaccine coverage, and enhanced infection prevention measures for food production in the Global South contrary to the focus on research and development of new antibiotics in the Global North) and to recalibrate global funding resources to address this need. We call on global leaders to redress the current response, which threatens mitigation of the antimicrobial resistance pandemic.